Amerise BioScie — 360° view

Amerise BioScie, a company in the Plastic Products - Industrial industry, reported revenue of ₹0.08 crore and net profit of ₹0.06 crore for the March 2026 quarter.

Amerise BioScie (BSE: AMERISE) closed at ₹0.81 on 20 Nov 2026, up 19.1% over the past year. Its market capitalisation is ₹5 crore.

Share price
₹0.81 (20 Nov 2026)
Market cap
₹5 Cr (20 Nov 2026)
Revenue
₹0 Cr (March 2026 quarter)
Net profit
₹0 Cr (March 2026 quarter)
ROCE
0.37% (FY26)
ROE
0.37% (FY26)
Book value
₹0.80 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹1.03 / ₹0.50 (20 Nov 2026)
1-year return
19.1% (to 20 Nov 2026)
Sector
Industrials
Industry
Plastic Products - Industrial
Symbol
BSE: AMERISE

Incorporated in 1984, Amerise Biosciences Ltd specializes in NDA, 505(b)(2), and complex formulations.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.